Image

A Mixed Intervention to Improve Resilience for Patient With Neurocognitive Disorders

A Mixed Intervention to Improve Resilience for Patient With Neurocognitive Disorders

Recruiting
60 years and older
All
Phase N/A

Powered by AI

Overview

The study aims to test a program combining cognitive behavioral therapy techniques, positive psychology techniques, mindfulness meditation and yoga, in order to improve resilience in patient with minor cognitive disorder.

This intervention will be compared to a control group, but also with a group testing another intervention (an intervention that does not improve resilience in the elderly, namely a "cognitive stimulation" intervention) in order to ensure that the effect potentially obtained is not due to the simple management of the participant.

The duration of the intervention will be 3 months, with an evaluation directly before and after the intervention.

In addition, in order to best evaluate the effectiveness of the interventions over time, two follow-up measurements will be proposed: a measurement one month after the intervention, then a final one three months after the intervention.

Eligibility

Inclusion Criteria:

  1. Man or Woman aged > 60 years
  2. Have a minor neurocognitive disorder according to the criteria of the DSM 5
  3. Score of 145 or less on the Wagnild and Young Resilience Scale (RS) (Wagnild, 2009).
  4. Subject able to read and write French;
  5. Subject beneficiaries of a social security scheme;
  6. Ability to understand and sign free and informed consent.

Exclusion Criteria:

  1. Subject already practicing meditation and/or yoga and/or Tai Chi
  2. Subject currently undergoing psychological therapy (whatever the approach)
  3. Subject with a major hearing, visual or motor disability likely to interfere with the proposed interventions or the performance of assessments;
  4. Presence and/or recent history (within the last 5 years prior to inclusion in the study) of major psychiatric disorders (e.g., schizophrenia, severe depression, addiction, bipolar disorders, psychotic disorders, risk of dissociation, panic attack, generalized anxiety disorder, etc.)
  5. If taking psychotropic treatment, the dose must have been stable for 4 weeks
  6. Vulnerable persons are defined in Articles L1121-5 to -8

Study details
    Cognitive Disorder

NCT06801171

Centre Hospitalier Universitaire de Nice

15 May 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.